BNC Korea Co., Ltd. (KOSDAQ:256840)
South Korea · Delayed Price · Currency is KRW 6,050.00
+930.00 (18.16%)
Nov 4, 2025, 3:30 PM KST
BNC Korea Market Cap
BNC Korea has a market cap or net worth of 413.79 billion as of November 4, 2025. Its market cap has increased by 11.41% in one year.
Market Cap
413.79B
Enterprise Value
342.21B
Revenue
99.34B
Ranking
n/a
PE Ratio
25.97
Stock Price
6,050.00
Market Cap Chart
Since November 18, 2019, BNC Korea's market cap has increased from 15.37B to 413.79B, an increase of 2,591.58%. That is a compound annual growth rate of 73.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 413.79B | 50.06% |
| Dec 30, 2024 | 275.74B | 12.30% |
| Dec 28, 2023 | 245.55B | -20.03% |
| Dec 29, 2022 | 307.06B | -78.68% |
| Dec 30, 2021 | 1.44T | 557.65% |
| Dec 30, 2020 | 219.01B | 174.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.68T |
| ALTEOGEN | 27.97T |
| SK Biopharmaceuticals | 9.05T |
| Yuhan | 8.83T |
| HLB Co., Ltd. | 6.38T |
| Peptron | 6.31T |
| PharmaResearch | 5.61T |